BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3084221)

  • 1. Mineralocorticoid activity of 19-hydroxyaldosterone, 19-nor-aldosterone, and 3 beta-hydroxy-delta 5-aldosterone: relative potencies measured in two bioassay systems.
    Morris DJ; Brem AS; Saccoccio NA; Pacholski M; Harnik M
    Endocrinology; 1986 Jun; 118(6):2505-9. PubMed ID: 3084221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone.
    Kenyon CJ; Brem AS; McDermott MJ; Deconti GA; Latif SA; Morris DJ
    Endocrinology; 1983 May; 112(5):1852-6. PubMed ID: 6403339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies of the mineralocorticoid activity of 19-oxo-deoxycorticosterone.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Endocrinology; 1984 Aug; 115(2):535-7. PubMed ID: 6745168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18-Substituted steroids. Part 18. Chemical synthesis and mineralocorticoid activity of 2 alpha- and 2 beta-hydroxyaldosterone.
    Kirk DN; Schröder MH; Latif SA; Souness GW; Morris DJ
    Steroids; 1993 Feb; 58(2):59-63. PubMed ID: 8484185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldosterone metabolism in combined isolated perfused rat liver and kidney.
    Egfjord M; Daugaard H; Olgaard K
    Am J Physiol; 1991 Apr; 260(4 Pt 2):F536-48. PubMed ID: 2012206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid-induced protein synthesis in giant-toad (Bufo marinus) urinary bladders. Correlation with natriferic activity.
    Geheb M; Alvis R; Owen A; Hercker E; Cox M
    Biochem J; 1984 Feb; 218(1):221-8. PubMed ID: 6424655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "mineralocorticoid-like" actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318.
    Souness GW; Morris DJ
    Endocrinology; 1991 Nov; 129(5):2451-6. PubMed ID: 1657575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mineralocorticoid antagonist activity of an 11 beta,18-oxidopregnane.
    Ulick S; Marver D; Adam WR; Funder JW
    Endocrinology; 1979 May; 104(5):1352-6. PubMed ID: 436780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralo- and glucocorticoid effects on renal excretion of electrolytes.
    Campen TJ; Vaughn DA; Fanestil DD
    Pflugers Arch; 1983 Oct; 399(2):93-101. PubMed ID: 6647008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat.
    Souness GW; Morris DJ
    Endocrinology; 1989 Mar; 124(3):1588-90. PubMed ID: 2917528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent aldosterone metabolism in toad urinary bladder.
    Brem AS; Pacholski M; Morris DJ
    Am J Physiol; 1988 Apr; 254(4 Pt 2):F547-53. PubMed ID: 3128118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New mineralocorticoids: 5alpha-dihydroaldosterone and 5alpha-dihydro-11-deoxycorticosterone.
    Sekihara H; Island DP; Liddle GW
    Endocrinology; 1978 Oct; 103(4):1450-2. PubMed ID: 744157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of aldosterone-induced antinatriuresis and kaliuresis by actinomycin D.
    Horisberger JD; Diezi J
    Am J Physiol; 1984 Feb; 246(2 Pt 2):F201-4. PubMed ID: 6696121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid inhibition of mineralocorticoid action in the rat.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Clin Sci (Lond); 1984 Sep; 67(3):329-35. PubMed ID: 6380888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid-specificity of aldosterone-induced protein synthesis in giant-toad (Bufo marinus) urinary bladders.
    Geheb M; Alvis R; Hercker E; Cox M
    Biochem J; 1983 Jul; 214(1):29-35. PubMed ID: 6412695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal receptor-binding activity of reduced metabolites of aldosterone: evidence for a mineralocorticoid effect outside of the classic aldosterone receptor system.
    Gomez-Sanchez CE; Smith JS; Ferris MW; Gomez-Sanchez EP
    Endocrinology; 1984 Aug; 115(2):712-5. PubMed ID: 6086276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of mineralocorticoid activity of aldosterone by 18-hydroxy-corticosterone and 18-hydroxy-19-nor-corticosterone in adrenalectomized rats.
    Rosenthal T; Shani M; Peleg E; Harnik M
    Endocr Res; 1990; 16(2):185-91. PubMed ID: 2344835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18-oxocortisol, a naturally occurring mineralocorticoid agonist.
    Ulick S; Land M; Chu MD
    Endocrinology; 1983 Dec; 113(6):2320-2. PubMed ID: 6641637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.